ZIOPTAN is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Thea Pharma Inc.. The primary component is Tafluprost.
Product ID | 82584-609_ec1dfc7a-46bb-7414-e053-2995a90a9929 |
NDC | 82584-609 |
Product Type | Human Prescription Drug |
Proprietary Name | ZIOPTAN |
Generic Name | Tafluprost |
Dosage Form | Solution/ Drops |
Route of Administration | OPHTHALMIC |
Marketing Start Date | 2022-10-28 |
Marketing Category | NDA / |
Application Number | NDA202514 |
Labeler Name | Thea Pharma Inc. |
Substance Name | TAFLUPROST |
Active Ingredient Strength | 0 mg/mL |
Pharm Classes | Increased Prostaglandin Activity [PE], Prostaglandin Analog [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-10-28 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
17478-609 | ZIOPTAN | tafluprost |
82584-609 | ZIOPTAN | Tafluprost |
0781-6184 | Tafluprost | Tafluprost |
65302-062 | Tafluprost | Tafluprost |
66993-429 | Tafluprost Ophthalmic | tafluprost |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ZIOPTAN 85091319 4161745 Live/Registered |
Merck Sharp & Dohme Corp. 2010-07-23 |